Results 1 to 10 of about 9,999 (256)

A case of left ventricular free wall rupture after insertion of an IMPELLA® left ventricular assist device diagnosed by transesophageal echocardiography [PDF]

JA Clinical Reports, 2021
Background The IMPELLA® is a minimally invasive left ventricular assist device. We report a case in which transesophageal echocardiography (TEE) was useful in diagnosis of left ventricular rupture after IMPELLA® insertion. Case presentation A 75-year-old
Akito Mizuno, Shuji Kawamoto, Shuji Uda, Kenichiro Tatsumi, Chikashi Takeda, Tomoharu Tanaka, Kazuhiko Fukuda   +6 more
doaj   +2 more sources

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study [PDF]

Journal of Cardiovascular Development and Disease, 2023
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion.
Beatrice De Lazzari, Massimo Capoccia, Roberto Badagliacca, Selim Bozkurt, Claudio De Lazzari   +4 more
doaj   +5 more sources

Trends in Veno‐Arterial Extracorporeal Life Support With and Without an Impella or Intra‐Aortic Balloon Pump for Cardiogenic Shock [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Mechanical circulatory support devices, such as the intra‐aortic balloon pump (IABP) and Impella, are often used in patients on veno‐arterial extracorporeal life support (VA‐ECLS) with cardiogenic shock despite limited supporting clinical ...
Michael J. Hendrickson, Vardhmaan Jain, Kirtipal Bhatia, Christopher Chew, Sameer Arora, Joseph S. Rossi, Pedro Villablanca, Navin K. Kapur, Aditya A. Joshi, Arieh Fox, Kiran Mahmood, Edo Y. Birati, Mark J. Ricciardi, Arman Qamar   +13 more
doaj   +3 more sources

Inflammatory and Hemolytic Responses of Microaxial Flow Pump Temporary Ventricular Assist Devices via Axillary Access in Cardiogenic Shock [PDF]

Medicina
Background and Objectives: The use of temporary left ventricular assist devices (tLVADs) for patients suffering from cardiogenic shock (CS) is becoming more common.
Leonie Schmack, Sadeq Ali-Hasan-Al-Saegh, Alexander Weymann, Nikolaus Pizanis, Payam Akhyari, Alina Zubarevich, Jasmin Sarah Hanke, Aron-Frederik Popov, Arjang Ruhparwar, Tienush Rassaf, Markus Kamler, Peter Luedike, Bastian Schmack   +12 more
doaj   +2 more sources

A Review of Bleeding Risk with Impella-Supported High-Risk Percutaneous Coronary Intervention [PDF]

, 2020
Complex, high-risk percutaneous coronary intervention (HR-PCI) is increasingly being performed, often with mechanical circulatory support (MCS), though to date, there are limited randomised data on the efficacy of MCS for HR-PCI.
Dahle, Thom G, Kaki, Amir, Vetrovec, George W   +2 more
core   +4 more sources

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients [PDF]

Frontiers in Cardiovascular Medicine, 2020
Background: In-hospital mortality in acute myocardial infarction-related cardiogenic shock (AMI-CS) remains high. The only adequately powered randomized trial showed no benefit of routine use of the intra-aortic balloon pump in AMI-CS.
Andreas Schäfer, Nikos Werner, Nikos Werner, Daniel Burkhoff, Jan-Thorben Sieweke, Andreas Zietzer, Maryna Masyuk, Nanna Louise Junker Udesen, Ralf Westenfeld, Jacob Eifer Møller   +9 more
doaj   +3 more sources

Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience [PDF]

Frontiers in Cardiovascular Medicine, 2023
IntroductionCardiogenic shock (CS) is a severe syndrome with poor prognosis. Short-term mechanical circulatory support with Impella devices has emerged as an increasingly therapeutic option, unloading the failing left ventricle (LV) and improving ...
M. V. Matassini, M. Marini, A. Angelozzi, L. Angelini, M. Shkoza, P. Compagnucci, U. Falanga, I. Battistoni, G. Pongetti, M. Francioni, T. Piva, A. Mucaj, E. Nicolini, A. Maolo, M. Di Eusanio, C. Munch, A. Dello Russo, G. Perna   +17 more
doaj   +3 more sources

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock [PDF]

Open Heart, 2019
Objective We investigated the benefit of Impella, a modern percutaneous mechanical support (pMCS) device, versus former standard intra-aortic balloon pump (IABP) in acute myocardial infarction complicated by cardiogenic shock (AMICS).Methods This single ...
Ulf Landmesser, Brunilda Alushi, Andel Douedari, Georg Froehlig, Wulf Knie, Thomas H Wurster, David M Leistner, Barbara-Elisabeth Staehli, Hans-Christian Mochmann, Burkert Pieske, Florian Krackhardt, Carsten Skurk   +11 more
doaj   +2 more sources

Left ventricular perforation by Impella 5.5 during surgery for postinfarction ventricular septal rupture [PDF]

The Egyptian Heart Journal
Background The perioperative use of the Impella 5.5 has been increasing recently; however, the left ventricular perforation by this device during surgery has not been reported to date.
Hisato Ito, Saki Bessho, Yu Shomura, Keishi Moriwaki, Kaoru dohi, Motoshi Takao   +5 more
doaj   +2 more sources

Thrompella: Acute Impella Thrombosis During Ecpella Support [PDF]

, 2023
We present a case of acute Impella thrombosis during Ecpella support in a 48-year-old man listed for a heart transplant. After two weeks of Ecpella support, echocardiography revealed a 2.6 x 1.1 cm mobile thrombus attached to the Impella inlet (Video ...
Araj, Faris, Hackmann, Amy E, Hall, Hurst M   +2 more
core   +2 more sources